Logo image of SJ

SCIENJOY HOLDING CORP-A (SJ) Stock Fundamental Analysis

NASDAQ:SJ - Nasdaq - VGG7864D1125 - Common Stock - Currency: USD

0.87  -0.03 (-3.33%)

Fundamental Rating

5

SJ gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 71 industry peers in the Entertainment industry. SJ has an excellent financial health rating, but there are some minor concerns on its profitability. SJ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year SJ was profitable.
SJ had positive earnings in 4 of the past 5 years.
Each year in the past 5 years SJ had a positive operating cash flow.
SJ Yearly Net Income VS EBIT VS OCF VS FCFSJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

1.2 Ratios

The Return On Assets of SJ (-5.01%) is comparable to the rest of the industry.
SJ has a Return On Equity (-5.88%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 3.30%, SJ is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SJ is significantly below the industry average of 88.00%.
The last Return On Invested Capital (3.30%) for SJ is well below the 3 year average (10.09%), which needs to be investigated, but indicates that SJ had better years and this may not be a problem.
Industry RankSector Rank
ROA -5.01%
ROE -5.88%
ROIC 3.3%
ROA(3y)8.78%
ROA(5y)20.32%
ROE(3y)11.66%
ROE(5y)31.84%
ROIC(3y)10.09%
ROIC(5y)28.57%
SJ Yearly ROA, ROE, ROICSJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 100 150

1.3 Margins

With a decent Operating Margin value of 3.04%, SJ is doing good in the industry, outperforming 65.15% of the companies in the same industry.
SJ's Operating Margin has declined in the last couple of years.
SJ has a Gross Margin of 14.78%. This is amonst the worse of the industry: SJ underperforms 86.36% of its industry peers.
SJ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.04%
PM (TTM) N/A
GM 14.78%
OM growth 3Y-53.94%
OM growth 5Y-36.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.04%
GM growth 5Y-8.07%
SJ Yearly Profit, Operating, Gross MarginsSJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 5 10 15 20

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SJ is creating some value.
SJ has more shares outstanding than it did 1 year ago.
SJ has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SJ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SJ Yearly Shares OutstandingSJ Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
SJ Yearly Total Debt VS Total AssetsSJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.99 indicates that SJ is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.99, SJ belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
There is no outstanding debt for SJ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.99
ROIC/WACC0.44
WACC7.51%
SJ Yearly LT Debt VS Equity VS FCFSJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.47 indicates that SJ has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.47, SJ belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
SJ has a Quick Ratio of 3.47. This indicates that SJ is financially healthy and has no problem in meeting its short term obligations.
SJ has a better Quick ratio (3.47) than 87.88% of its industry peers.
Industry RankSector Rank
Current Ratio 3.47
Quick Ratio 3.47
SJ Yearly Current Assets VS Current LiabilitesSJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

SJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 251.71%, which is quite impressive.
Looking at the last year, SJ shows a decrease in Revenue. The Revenue has decreased by -8.25% in the last year.
SJ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.54% yearly.
EPS 1Y (TTM)251.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.65%
Revenue 1Y (TTM)-8.25%
Revenue growth 3Y6.22%
Revenue growth 5Y14.54%
Sales Q2Q%-12.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year940.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SJ Yearly Revenue VS EstimatesSJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SJ Yearly EPS VS EstimatesSJ Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.44, the valuation of SJ can be described as very cheap.
Based on the Price/Earnings ratio, SJ is valued cheaply inside the industry as 93.94% of the companies are valued more expensively.
SJ is valuated cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.44
Fwd PE N/A
SJ Price Earnings VS Forward Price EarningsSJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

SJ's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SJ is cheaper than 98.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.29
SJ Per share dataSJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SJ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCIENJOY HOLDING CORP-A

NASDAQ:SJ (2/24/2025, 9:42:05 AM)

0.87

-0.03 (-3.33%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)09-04 2024-09-04/amc
Earnings (Next)N/A N/A
Inst Owners0.26%
Inst Owner Change-47.38%
Ins OwnersN/A
Ins Owner Change0%
Market Cap36.41M
Analysts0
Price TargetN/A
Short Float %0.01%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.44
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.44
EV/EBITDA 0.29
EPS(TTM)0.16
EY18.39%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.9
BVpS3.94
TBVpS2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.01%
ROE -5.88%
ROCE 3.61%
ROIC 3.3%
ROICexc 4.02%
ROICexgc 9.46%
OM 3.04%
PM (TTM) N/A
GM 14.78%
FCFM N/A
ROA(3y)8.78%
ROA(5y)20.32%
ROE(3y)11.66%
ROE(5y)31.84%
ROIC(3y)10.09%
ROIC(5y)28.57%
ROICexc(3y)13.77%
ROICexc(5y)86.92%
ROICexgc(3y)31.79%
ROICexgc(5y)N/A
ROCE(3y)11.04%
ROCE(5y)31.78%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-58.36%
ROICexc growth 3Y-66.65%
ROICexc growth 5Y-65.42%
OM growth 3Y-53.94%
OM growth 5Y-36.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.04%
GM growth 5Y-8.07%
F-ScoreN/A
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.47
Quick Ratio 3.47
Altman-Z 2.99
F-ScoreN/A
WACC7.51%
ROIC/WACC0.44
Cap/Depr(3y)20.78%
Cap/Depr(5y)36.32%
Cap/Sales(3y)0.08%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)251.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.25%
Revenue growth 3Y6.22%
Revenue growth 5Y14.54%
Sales Q2Q%-12.93%
Revenue Next Year940.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.07%
EBIT growth 3Y-51.07%
EBIT growth 5Y-26.98%
EBIT Next Year7366.5%
EBIT Next 3Y677.61%
EBIT Next 5Y288.75%
FCF growth 1Y84.48%
FCF growth 3Y-12.83%
FCF growth 5Y-0.86%
OCF growth 1Y78.29%
OCF growth 3Y-12.9%
OCF growth 5Y-0.87%